Abstract
Increasing numbers of children with nontuberculous mycobacterial (NTM) infections have been reported from many pediatric hospitals. The most common manifestation, cervical lymphadenitis, is most common in preschool-aged, immunocompetent children, and surgical excision may be curative. Isolated skin and soft tissue infections (SSTIs) can be seen in immunocompetent children after direct inoculation from penetrating trauma or can be the first presentation of disseminated disease in immunocompromised hosts. Disseminated and pulmonary NTM infection is almost always seen in children with either immunocompromising conditions (primary or acquired) or in children with conditions predisposing them to parenchymal lung damage (e.g., cystic fibrosis). While the treatment principles are the same as for adults, many children may have paucibacillary disease and may thus either require fewer medications or a shorter duration of therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blyth CC, Best EJ, Jones CA, et al. Nontuberculous mycobacterial infection in children: a prospective national study. Pediatr Infect Dis J. 2009;28(9):801–5.
Haverkamp MH, Arend SM, Lindeboom JA, et al. Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis. 2004;39:450–6.
Carvalho AC, Codecasa L, Pinsi G, et al. Differential diagnosis of cervical mycobacterial lymphadenitis in children. Pediatr Infect Dis J. 2010;29(7):629–33.
Gallivan M, Shah N, Flood J. Epidemiology of Mycobacterium bovis disease, California, USA, 2003–2011. Emerg Infect Dis. 2015;21(3):435–43.
Kuchukhidze G, Kasradze A, Dolakidze T, et al. Increase in lymphadenitis cases after shift in BCG vaccine strain. Emerg Infect Dis. 2015;21(9):1677–9.
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. Available online at: www.bcgatlas.org. Accessed 11 Oct 2016.
Haimi-Cohen Y, Zeharia A, Mimouni M, et al. Skin indurations in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis. 2001;33(10):1786–8.
Lindeboom JA, Smets AM, Kuijper EJ, et al. The sonographic characteristics of nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Radiol. 2006;36(10):1063–7.
Robson CD. Imaging of granulomatous lesions of the neck in children. Radiol Clin N Am. 2000;38(5):969–77.
Ellison E, Lapuerta P, Martin SE. Fine needle aspiration diagnosis of mycobacterial lymphadenitis: sensitivity and predictive value in the United States. Acta Cytol. 1999;32(2):153–7.
Lindeboom JA. Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis. 2011;52(2):180–4.
Haimi-Cohen Y, Markus-Eidlitz T, Amir J, Zeharia A. Long-term follow-up of observation-only management of nontuberculous mycobacterial lymphadenitis. Clin Pediatr (Phila). 2016;55(12):1160–4.
Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, et al. Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J. 2008;27(10):920–2.
Lindeboom JA. Surgical treatment for nontuberculous mycobacterial (NTM) cervicofacial lymphadenitis in children. J Oral Maxillofac Surg. 2012;70(2):345–8.
Lindeboom JA, Lindeboom R, Bruijnesteijn van Coppenraet ES, et al. Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Infect Dis J. 2009;28(11):1028–30.
Parker NP, Scott AR, Finkelstein M, et al. Predicting surgical outcomes in pediatric cervicofacial mycobacterial lymphadenitis. Ann Otol Rhinol Laryngol. 2012;121(7):478–84.
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.
Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147–95.
Cuello-Garcia CA, Perez-Gaxiola G, Jimenez Gutierrez C. Treating BCG-induced disease in children. Cochrane Database Syst Rev. 2013;1:CD008300.
Banani SA, Alborzi A. Needle aspiration for suppurative post-BCG adenitis. Arch Dis Child. 1994;71(5):446–7.
Tebruegge M, Pantazidou A, MacGregor D, et al. Nontuberculous mycobacterial disease in children – epidemiology, diagnosis & management at a tertiary center. PLoS One. 2016;11(1):e0147513.
Asiimwe BB, Bagyenzi GB, Sengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis. 2013;13:88.
Pham-Huy A, Robinson JL, Tapiero B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: a pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health. 2010;15(5):276–82.
Stone AB, Schelonka RL, Drehner DM, et al. Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J. 1992;11:960–4.
Arlotta A, Cefalo MG, Maurizi P, et al. Critical pulmonary infection due to nontuberculous mycobacterium in pediatric leukemia: report of a difficult diagnosis and review of pediatric series. J Pediatr Hematol Oncol. 2014;36(1):66–70.
Haverkamp MH, van de Vosse E, van dissel JT. Nontuberculous mycobacterial infections in children with inborn errors of the immune system. J Infect. 2014;68(Suppl 1):S134–50.
Safdar A, White DA, Stover D, et al. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am J Med. 2002;113(9):756–9.
Qu H-Q, Fisher-Hoch SP, McCormick JB. Molecular immunity to mycobacteria; knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases. Int J Infect Dis. 2011;15(5):e305–13.
Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335(26):1941–9.
Floto RA, Olivier KN, Saiman L, et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71(1):1–22.
Adjermian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States. Screening practices and environmental risk. Am J Respir Crit Care Med. 2014;190(5):581–6.
Leung JM, Olivier KN. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med. 2013;19(6):662–9.
Harris KA, Underwood A, Kenna DTD, et al. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of Mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients. Clin Infect Dis. 2015;60(7):1007–16.
Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet. 2013;381(9877):1551–60.
Bryant JM, Grogono DM, Rodriguez-Rincon D, et al. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science. 2016;354(6313):751–7.
Nolt D, Michaels MG, Wald ER. Intrathoracic disease from nontuberculous mycobacteria in children: two cases and a review of the literature. Pediatrics. 2003;112(5):e434.
Freeman AF, Olivier KN, Rubio TT, et al. Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children. Pediatr Pulmonol. 2009;44(11):1051–6.
Gupta SK, Katz BZ. Intrathoracic disease associated with Mycobacterium avium-intracellulare complex in otherwise healthy children: diagnostic and therapeutic considerations. Pediatrics. 1994;94(5):741–2.
Lopez-Varela E, Garcia-Basteiro AL, Santiago B, et al. Nontuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. Lancet Respir Med. 2015;3(3):244–56.
Fergie JE, Milligan TW, Henderson BM, et al. Intrathoracic Mycobacterium avium complex infection in immunocompetent children: case report and review. Clin Infect Dis. 1997;24(2):250–3.
Levelink B, de Vries E, van Dissel JT, et al. Pulmonary Mycobacterium avium intracellulare infection in an immunocompetent child. Pediatr Infect Dis J. 2004;23(9):892.
Kröner C, Griese M, Kappler M, et al. Endobronchial lesions caused by nontuberculous mycobacteria in apparently healthy pediatric patients. Pediatr Infect Dis J. 2015;34(5):532–5.
del Rio Camacho G, Soriano Guillén L, Flandes Aldeyturriaga J, et al. Endobronchial atypical mycobacteria in an immunocompetent child. Pediatr Pulmonol. 2012;45(5):511–3.
Glatstein M, Scolnick D, Bensira L, et al. Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate. Pediatr Pulmonol. 2012;47(10):1034–7.
Osorio A, Kessler RM, Guruuprasad H, et al. Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child. Pediatr Radiol. 2001;31(12):848–51.
Kelsey DS, Chambers RT, Hudspeth AS. Nontuberculous mycobacterial infection presenting as a mediastinal mass. J Pediatr. 1981;98(3):431–2.
Dore ND, LeSouëf PN, Masters B, et al. Atypical mycobacterial pulmonary disease and bronchial obstruction in HIV-negative children. Pediatr Pulmonol. 1998;26(6):380–8.
Do PC, Nussbaum E, Moua J, et al. Clinical significance of respiratory isolates for Mycobacterium abscessus complex from pediatric patients. Pediatr Pulmonol. 2013;48(5):470–80.
Martiniano SL, Nick JA. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med. 2015;36(1):101–15.
Robinson PD, Harris KA, Aurora P, et al. Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species. Eur Respir J. 2013;41(5):1230–2.
Koh WJ, Stout JE, Yew W-W. Advances in the management of pulmonary disease due to Mycobacterium abscessus complex. Int J Tuberc Lung Dis. 2014;18(10):1141–8.
Johnson MG, Stout JE. Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review. Infection. 2015;43(6):655–62.
Lillis JV, Ansdell VE, Ruben K, et al. Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders. Clin Infect Dis. 2009;48(11):1541–6.
Franklin DJ, Starke JR, Brady MT, Brown BA, Wallace RJ Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am J Otol. 1994;15(3):313–20.
World Health Organization. Global leprosy update, 2013: reducing disease burden. Wkly Epidemiol Rec. 2014;89(36):389–400.
Kothavade RJ, Dhurat RS, Mishra SN, Kothavade UR. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis. 2013;32(2):161–88.
Toll A, Gallardo F, Ferran M, et al. Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Clin Exp Dermatol. 2005;30(6):649–51.
Sia TY, Taimur S, Blau DM, et al. Clinical and pathological evaluation of Mycobacterium marinum group skin infections associated with fish markets in New York City. Clin Infect Dis. 2016;62(5):590–5.
El Sahly HM, Septimus E, Soini H, et al. Mycobacterium simiae pseudo-outbreak resulting from a contaminated water supply in Houston, Texas. Clin Infect Dis. 2002;35(7):802–7.
World Health Organization. Leprosy elimination: WHO recommended MDT regimens. Available online at: http://www.who.int/lep/mdt/regimens/en/. Accessed 10/13/16.
World Health Organization. Treatment of Mycobacterium ulcerans disease (Buruli Ulcer). 2012. Available online at: http://apps.who.int/iris/bitstream/10665/77771/1/9789241503402_eng.pdf. Accessed 10/13/16.
Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis. 2005;41(10):1483–97.
Shachor-Meyouhas Y, Sprecher H, Eluk O, et al. An outbreak of Mycobacterium mucogenicum bacteremia in pediatric hematology-oncology patients. Pediatr Infect Dis J. 2011;30(1):30–2.
Department of Health and Human Services. Panel on opportunistic infections in HIV-exposed and HIV-infected children: guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. 2013. Available online at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. Accessed 13 Oct 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cruz, A.T., Starke, J.R. (2019). Nontuberculous Mycobacterial Disease in Pediatric Populations. In: Griffith, D. (eds) Nontuberculous Mycobacterial Disease. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-93473-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-93473-0_16
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-93472-3
Online ISBN: 978-3-319-93473-0
eBook Packages: MedicineMedicine (R0)